Michael Flentje
Papers
7
Total Citations
480
H-Index
7
About
Michael Flentje is a leading figure in precision radiation oncology, whose work has fundamentally advanced the accuracy of cancer treatments. His research centers on image-guided radiotherapy (IGRT) and the development of real-time motion compensation systems to counteract tumor movement during treatment. Flentje’s major contributions include pioneering the use of robotic HexaPOD treatment tables combined with cone-beam computed tomography (CBCT) for sub-millimeter patient positioning, as demonstrated in his highly cited 2007 papers (144 and 137 citations). He is perhaps best known for developing an adaptive tumor tracking system (ATTS) that enables real-time tumor tracking without implanted fiducial markers, using the therapeutic megavoltage beam itself—a novel approach detailed in his 2008 work (102 citations). This system, along with his semi-robotic 6-degree-of-freedom positioning for intracranial radiotherapy (29 citations), has set new standards for intrafractional motion management. Flentje’s research has directly improved the accuracy of treatments for prostate, intracranial, and other mobile tumors, with his dosimetric evaluations using robot-driven phantoms providing critical insights into the clinical impact of tumor motion. His work remains essential reading for medical physicists and radiation oncologists seeking to minimize treatment margins and enhance therapeutic outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Influence of Continuous Table Motion on Patient Breathing Patterns23 citations · 2010
- 7